News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
686,326 Results
Type
Article (41588)
Company Profile (254)
Press Release (644484)
Section
Business (205607)
Career Advice (2018)
Deals (35577)
Drug Delivery (81)
Drug Development (81214)
Employer Resources (168)
FDA (16114)
Job Trends (14934)
News (346851)
Policy (32897)
Tag
Academia (2631)
Africa (735)
Alliances (49911)
Alzheimer's disease (1148)
Approvals (16058)
Arizona (166)
Artificial intelligence (65)
Asia (37606)
Australia (6100)
Bankruptcy (352)
Best Places to Work (11316)
Biosimilars (63)
Biotechnology (121)
C2C Services and Suppliers (79505)
California (1370)
Canada (760)
Cancer (280)
Career advice (1683)
Cell therapy (95)
China (74)
Clinical research (63224)
Collaboration (91)
Colorado (51)
Connecticut (52)
COVID-19 (2512)
Cystic fibrosis (72)
Data (98)
Diabetes (54)
Diagnostics (5980)
Drug pricing (54)
Earnings (83842)
Employer resources (141)
Europe (80771)
Events (108437)
Executive appointments (65)
FDA (16228)
Florida (182)
Funding (73)
Gene therapy (70)
GLP-1 (497)
Government (4378)
Healthcare (18692)
Hotbed/Location (485085)
Idaho (56)
Illinois (217)
Indiana (123)
Infectious disease (2532)
Inflammatory bowel disease (88)
Interviews (307)
IPO (16240)
Job creations (3680)
Job search strategy (1450)
Kansas (92)
Layoffs (389)
Legal (7889)
Liver cancer (55)
Lung cancer (59)
Maine (49)
Management (52)
Manufacturing (65)
Maryland (325)
Massachusetts (1201)
Medical device (13071)
Medtech (13074)
Mergers & acquisitions (19100)
Metabolic disorders (199)
Michigan (107)
Minnesota (204)
Neuroscience (1247)
New Jersey (366)
New York (426)
NextGen Class of 2024 (6562)
Non-profit (4506)
North Carolina (540)
Northern California (645)
Obesity (123)
Ohio (96)
Opinion (174)
Pennsylvania (480)
People (56422)
Phase I (19635)
Phase II (27832)
Phase III (20821)
Pipeline (76)
Postmarket research (2562)
Preclinical (8430)
Rare diseases (105)
Real estate (5998)
Recruiting (63)
Regulatory (21437)
Research institute (2384)
Resumes & cover letters (352)
South America (1117)
Southern California (570)
Startups (3641)
Texas (160)
United States (6631)
Vaccines (450)
Washington State (145)
Weight loss (109)
Date
Today (44)
Last 7 days (562)
Last 30 days (2638)
Last 365 days (38287)
2024 (23895)
2023 (40542)
2022 (51710)
2021 (56265)
2020 (54590)
2019 (47052)
2018 (35444)
2017 (32658)
2016 (32061)
2015 (38135)
2014 (31893)
2013 (26950)
2012 (29130)
2011 (29782)
2010 (27724)
686,326 Results for "biolog inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for the diagnostic, nutrition and cell culture markets.
June 28, 2024
·
4 min read
Sponsored
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological
Sino Biological, Inc. has successfully concluded the acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc.
July 15, 2024
·
3 min read
Pharm Country
Neurotech Pharmaceuticals, Inc. Receives Priority Review of Biologics License Application (BLA) for NT-501 (revakinagene taroretcel) as a Treatment for Macular Telangiectasia Type 2 (MacTel)
Neurotech Pharmaceuticals, Inc. announces that the U.S. Food and Drug Administration (FDA), has determined that the Biologic License Application (BLA) for NT-501, an investigational encapsulated cell therapy for the treatment of MacTel, is sufficiently complete to permit a substantive review.
June 20, 2024
·
3 min read
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
Axogen, Inc. is pleased to announce that it has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License Application (BLA) for licensure of Avance Nerve Graft ® on May 15, 2024.
May 16, 2024
·
7 min read
NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility
NurExone Biologic Inc., a pioneering biopharmaceutical company is pleased to announce that its common shares are now quoted for trading on the OTCQB® Venture Market under the symbol NRXBF.
April 25, 2024
·
4 min read
Press Releases
Biologics Market Size to Reach USD 699.5 Billion by 2032, Impelled by Emergence of Advanced Drug Delivery Systems
Biologics Market Outlook 2024-2032:
August 8, 2024
·
14 min read
BioForest
Biolog Delves Into Characterizing Gut Microbiomes With the Launch of PreBioM Plates
Biolog, Inc., a leading provider of cell-based microbial identification and phenotypic profiling products and services, is excited to announce the launch of its new PreBioM™ microplate product line for microbiome analysis and organism selection.
June 11, 2024
·
2 min read
Policy
Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
Evotec SE announced that its Seattle-based subsidiary, Just - Evotec Biologics, Inc., was selected by the U.S. Department of Defense to develop an accelerated monoclonal antibody development and manufacturing solution for the DOD’s Manufacturing Optimization Program.
June 25, 2024
·
7 min read
Business
On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development
NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, welcomes Dr. Yona Geffen, as a consultant, to support the Company’s preclinical and clinical activities.
June 21, 2024
·
6 min read
Business
HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights
HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB) today reported financial results and recent business highlights for its first quarter ended March 31, 2024.
May 15, 2024
·
13 min read
1 of 68,633
Next
